Skip to content
While “37 million people in the United States are estimated to have chronic kidney disease (CKD),” most don’t know about it, according to the […]
National Kidney Month focuses on paths to better care Read More »
Rice University researchers have successfully eradicated advanced-stage ovarian and colorectal cancer in mice in as little as six days by implementing a potentially breakthrough
Implantable ‘drug factories’ eliminate ovarian, colorectal cancer in mice Read More »
The Senate Finance Committee held a hearing yesterday on “prescription drug price inflation,” during which witnesses testified that price controls would limit biotechnology innovation
Experts tell Senate drug price controls interfere with innovation, R&D Read More »
The EMPA-KIDNEY clinical trial of Jardiance (empagliflozin) for adults with chronic kidney disease (CKD) was deemed successful enough to stop early by the trial’s
Jardiance clinical trial deemed successful enough to stop early Read More »
Bacterial and fungal infections that follow on the back of SARS-CoV-2 coronavirus have forced doctors to increase the use of antibiotics and antifungal medications,
Squash Superbugs Day of Action to address medical and market challenges of AMR Read More »
Much of the Russian oil that America has decided to forgo would be replaced with biofuels under the Home Front Energy Independence Act, unveiled
Bipartisan bill would replace banned Russian oil with biofuel Read More »
The Lancet HIV cautioned in an article published Friday that organizations participating in Ukraine’s HIV response are fighting to sustain treatment and other services
War in Ukraine leaves HIV patients without treatment Read More »
The Biotechnology Innovation Organization (BIO) last week warned that the Russian Government’s plan to ignore intellectual property rights will not only hurt the country’s
BIO warns Russian Government about cost of ignoring IP Read More »
Moderna, Inc., a pioneer in the field of messenger RNA (mRNA) medicines and vaccines, has revealed its global public health strategy, which includes four
Moderna targets 15 pathogens in its Global Public Health Strategy Read More »
The U.S. Food and Drug Administration (FDA) on March 4 authorized a shelf-life extension, from six to nine months, for the Janssen COVID-19 vaccine
Janssen COVID-19 vaccine’s shelf-life extended to 9 months Read More »
